Amprion Secures More Capital to Advance Novel Neurologic Diagnostics to Market A global biotechnology company focused on developing diagnoses for neurodegenerative disorders, Amprion, has secured $6 million in the initial close of its $15 million series B funding round. Read more: https://nextdigitalhealth.com/funding-news/amprion-secures-more-capital-to-advance-novel-neurologic-diagnostics-to-market/ #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #Biotech #BrainDiagnostics #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal